Hardy Reed LLC Sells 8,831 Shares of Merck & Co., Inc. $MRK

Hardy Reed LLC significantly reduced its stake in Merck & Co., Inc. by selling 8,831 shares, leaving it with 6,507 shares valued at $546,000. This follows recent insider selling by EVP Jennifer Zachary and CEO Robert M. Davis, totaling 320,176 shares worth approximately $38.3 million by insiders in the last three months. Despite insider exits, Merck maintains an average “Moderate Buy” rating from analysts with a target price of $123.71, recently beat Q4 EPS estimates, and announced a $0.85 quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
0/400
No comments
  • Pin

Trade Crypto Anywhere Anytime
qrCode
Scan to download Gate App
Community
  • 简体中文
  • English
  • Tiếng Việt
  • 繁體中文
  • Español
  • Русский
  • Français (Afrique)
  • Português (Portugal)
  • Bahasa Indonesia
  • 日本語
  • بالعربية
  • Українська
  • Português (Brasil)